Discussions marquées : Injection device

Microarray patches for dermal delivery of vaccines

Hello all, Microarray patches (MAPs) are under development for delivering vaccine into the skin. The technology has exciting potential for application to immunization programs. PATH is looking for input from experts in low- and middle-income country immunization programs about the feasibility of MAPs to facilitate immunization, especially for novel delivery scenarios like self-administration of vaccine at home, as well as more traditional immunization settings in LMICs. We have created an online survey as a forum for collecting your feedback. We value your opinion on this topic. The survey will be open for one week and should take no more than 20 minutes: https://www.surveymonkey.com/r/vaccinepatch The results will inform dialogue with vaccine manufacturers and other stakeholders as we work to advance this exciting new method for vaccine delivery. I encourage you to share your opinion in the survey and to forward the link above to other colleagues, particularly those in LMIC immunization programs. I’m always happy to chat in person as well and have included my contact information below. I hope to hear from you. Best regards, Sarah     Sarah McGray Program Officer, Devices & Tools PATH Tel: 206.285.3500 Skype: smcgray Email: smcgray@path.org www.path.org

Your Perspective on Disposable-Syringe Jet Injectors

Dear colleagues, PATH is evaluating a new generation of needle-free jet injectors, known as disposable-syringe jet injectors (DSJIs),for vaccine deliveryin low and middle-income countries. We are writing to request your participation in a 15-minute survey https://www.surveymonkey.com/s/629RM3C as we believe your input and perspective will be extremely valuable in planning for impactful next steps. Thank you in advance. With appreciation, Jody Garcia
  • Page :
  • 1